ÄÔÊÒÖÜΧ°×ÖÊÈí»¯,periventricular leukomalaciaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õý³£²Î¿¼Öµ,Normal reference valueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÎÑ׿ËÀײ®¸Ë¾ú,Klebsiella pneumoniaeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔѪ˨,cerebral thrombosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ̵֤,Phlegm syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²ñºúÔíÜÕa,saikosaponin aÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂÎ÷À¼ÍÃ,New Zealand rabbitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »ðÆ÷ÉË,Firearm woundÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ðļ¡³ÉÏËάϸ°û,Cardiac fibroblastsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×µ-»ùµ×¶¯Âö¹©Ñª²»×ã,Vertebrobasilar insufficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞ¾úÐÔËɶ¯,Aseptic looseningÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹Üͨ·,Vascular accessÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔÉöС¹Ü»µËÀ,Acute tubular necrosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¡Àí¸Ä±ä,pathological changesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ԭλÒÆÖ²,orthotopic transplantationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹ÜÎǺÏ,vascular anastomosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö×ÁöÄ£ÐÍ,Tumor modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼õѹ²¡,decompression sicknessÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔÐÄÁ¦Ë¥½ß,acute heart failureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Òìλ¹Ç»¯,heterotopic ossificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¨¹Ì´¼õ¥×ªÔ˵°°×,cholesteryl ester transfer proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Èںϵ°°×ÖÊÀà,fusion proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½ÇĤɢ¹â,corneal astigmatismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë®ºÏÂÈÈ©,chloral hydrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÐÒ©¸´·½,Chinese herbal compoundÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöËðÉË,renal injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë«ÖØPCR,Duplex PCRÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ¹ÜÄÚƤ×æϸ°û,endothelial progenitor cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʵÑéÐÔ×ÔÉíÃâÒßÐÔÖØÖ¢¼¡ÎÞÁ¦,Experimental autoimmune myasthenia gravisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÒ±ÚÁö,Ventricular aneurysmÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½á³¦ºÚ±ä²¡,Melanosis coliÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÛÖ×Áö,Eye neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µç×迹,electrical impedanceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« à­ßøËá,quinolinic acidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »îÌå¸ÎÒÆÖ²,Living donor liver transplantationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´óÄÔÖж¯Âö×èÈû,middle cerebral artery occlusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Âé×í»Ö¸´ÆÚ,Anesthesia recovery periodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¡Ö¤½áºÏ,combination of disease and syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ESR»ùÒò,ESR geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔÅųⷴӦ,chronic rejectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÷¿°å,epiphyseal plateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔ¹ÇËèÑ×,Chronic osteomyelitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡Ðļ¡²¡±ä,diabetic cardiomyopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë¥ÀÏÄ£ÐÍ,Aging modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔµÍÑõ,acute hypoxiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÇÐÎ̬·¢Éúµ°°×,Bone morphogenetic proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 賦¼¤ËØ,gastrointestinal hormoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸´ºÏÂé×í,combined anesthesiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Í·Ó°²âÁ¿·ÖÎö,cephalometric analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« K562/A02ϸ°û,K562/A02 cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×Ô·¢ÐÔ¸ßѪѹ,Spontaneous HypertensionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÕ±¾ÑªÎü³æ²¡,Schistosomiasis japonicaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѪҺÉú»¯,Blood BiochemistryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉÏò¢Ç°Ç£Òý,maxillary protractionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹Ú×´ñ¼,Coronary sinusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÔàÒÆÖ²,renal transplantationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« UWÒº,UW solutionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éö×éÖ¯,Renal TissueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´óÊóѪ½¬,rat plasmaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CT¹à×¢,CT perfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½ü½»BALB/c,inbred BALB/cÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¹ÖùÖ×Áö,Spinal neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾±¾²Âö,jugular veinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Âö³åÔëÉù,Impulse noiseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CO2Æø¸¹,CO2 pneumoperitoneumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ÌÑø²ãϸ°û,trophoblastÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾²Âöñ¼,venous sinusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÓÛÊäÄò¹ÜÁ¬½Ó²¿¹£×è,Ureteropelvic junction obstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÅÉäÐÔËðÉË,Radiation injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂÑԲϸ°û,Oval cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞëСÊó,hairless miceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ä£ÐÍÆÀ¼Û,model evaluationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½Ç¼ÓËÙ¶È,angular accelerationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½ðÊôµ°°×ø1×éÖ¯ÒÖÖƼÁ,Tissue-inhibitor of metalloproteinase-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Bϸ°ûÁÜ°ÍÁö,B cell lymphomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ñÐÔÐØĤ¼äƤÁö,Malignant pleural mesotheliomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÐΪÃô»¯,Behavioral sensitizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡Ä£ÐÍ,diabetic modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 賦Ô˶¯,Gastrointestinal motilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºËØÃô¸ÐÐÔÖ¸Êý,insulin sensitivity indexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½ºÔ­ÓÕµ¼ÐԹؽÚÑ×,Collagen-induced arthritisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐԽ᳦Ñ×,chronic colitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦Õ³Ä¤Í¨Í¸ÐÔ,intestinal permeabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ó¦Á¦ÐÔ¹ÇÕÛ,Stress fractureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´Ù»ÆÌåÉú³ÉËØ,luteinizing hormoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °ëë×°±ËáÌ춬°±Ëáµ°°×ø3,Caspase-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Î±£»¤,Lung protectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »·ºËÜÕËá,cyclic nucleotideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÇòÄÒµ¼¹Ü,Balloon catheterÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÕûºÏËئÁv¦Â3,integrin ¦Áv¦Â3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔÅųâ,chronic rejectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍÃÄ£ÐÍ,Rabbit modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃÚÄòÉúֳϵͳ,urogenital systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔ¸ßÑÛѹ,chronic ocular hypertensionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« È˹ÇËè¼ä³äÖʸÉϸ°û,Human mesenchymal stem cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ÂÈøÆ没¶¾B3,Coxsackievirus B3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔÑ×Ö¢,Acute inflammationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑôÐé,yang deficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ËÄÕï,four diagnostic methodsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ũ¶È¼«»¯,concentration polarizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
 ÉÏÒ»Ò³ 2 3 4 5 6 7 8 9 ÉÏÒ»Ò³